首页/数据集/PathFX identifications supported by on-going clinical trials.

PathFX identifications supported by on-going clinical trials.

NIAID Data Ecosystem2026-03-10 收录

肿瘤药物靶点验证

临床试验数据

数据链接：

https://figshare.com/articles/dataset/PathFX_identifications_supported_by_on-going_clinical_trials_/7437071 数据链接链接失效反馈

官方服务：

资源简介：

PathFX identifications supported by on-going clinical trials.

应用场景：

创建时间：

2018-12-07

相关数据集

Ligand binding to FARNESOID-X-RECEPTOR

蛋白质-配体对接

肿瘤药物靶点验证

Ligand binding to FARNESOID-X-RECEPTOR Descriptor: Bile acid receptor, COACTIVATOR PEPTIDE SRC-1 HD3, trans-4-({(2S)-2-cyclohexyl-2-[2-(2,6-dimethoxypyridin-3-yl)-5-fluoro-1H-benzimidazol-1-yl]acetyl}

Protein Data Bank Japan2024-05-22 更新40

Demographics and characteristics of intradermal and subcutaneous groups.

给药方式

临床试验数据

Demographics and characteristics of intradermal and subcutaneous groups.

Figshare2026-02-11 更新10

Transcriptomic profiling of LPS-stimulated macrophages to evaluate the effects of GTS-21

免疫调节转录组学

肿瘤药物靶点验证

The cholinergic anti-inflammatory pathway (CAP) is a neural mechanism that modulates immune responses. Macrophages express alpha 7 nicotinic acetylcholine receptors (alpha 7nAChRs), which play a cruci

NIAID Data Ecosystem00

Validation and invalidation of chemical probes for the human N-myristoyltransferases.

肿瘤药物靶点验证

N-肉豆蔻酰转移酶抑制剂

On-target, cell-active chemical probes are of fundamental importance in both chemical and cell biology, whereas the application of poorly-characterised probes often leads to invalid conclusions. Human

NIAID Data Ecosystem20

Clinical Trials Transformation Initiative's (CTTI) Trial Information through September 2024

临床试验数据

药物开发监管

A static copy of the AACT database (Pipe-Delimited Files). Monthly Archive of Static Copies: 20240927_export_ctgov.zip from https://aact.ctti-clinicaltrials.org/download.

Zenodo2024-10-23 更新00